Skip to content
Stork.AIstork.ai
AI Tool

AlphaMissense Review

AlphaMissense is a deep learning method developed by DeepMind for predicting the pathogenicity of missense variants in human proteins.

shipped Apr 2, 2026aifreemium
ai
AlphaMissense — product screenshot

Why it matters

1AlphaMissense classifies 89% of all 71 million possible missense variants in the human genome.
2The model achieved 90% precision when classifying a large subset of the ClinVar database.
3AlphaMissense data is integrated into major biological databases including Ensembl, UniProt, DECIPHER, and AlphaFold DB.
4Developed by Google DeepMind, AlphaMissense is an adaptation of the AlphaFold methodology.

Stork’s verdict on AlphaMissense

AlphaMissense covers 71 million possible missense variants, but its accuracy is gene-dependent.

overview

What is AlphaMissense?

AlphaMissense is a deep learning tool developed by Google DeepMind that enables researchers and clinicians to predict the pathogenicity of missense variants in human proteins. It assigns a score between 0 and 1, indicating the likelihood of a variant being disease-causing. This AI model, an adaptation of AlphaFold, is fine-tuned on human and primate variant population frequency databases, combining structural context and evolutionary conservation to classify variants as likely benign or likely pathogenic. Its primary use cases include refining diagnoses for rare genetic disorders, understanding the genetic underpinnings of complex traits, and accelerating research by providing a catalog of all possible 71 million missense variants in the human genome.

features

Key Features of AlphaMissense

AlphaMissense provides a comprehensive suite of capabilities for genetic variant analysis, leveraging advanced deep learning techniques to offer precise predictions and insights.

  • Predicts the pathogenicity of missense variants in human proteins with a score between 0 and 1.
  • Classifies variants as either likely benign or likely pathogenic.
  • Utilizes a deep learning model adapted from AlphaFold, incorporating structural context.
  • Leverages evolutionary conservation data from human and primate variant population frequency databases.
  • Identifies mutational hot/cold spots within protein structures.
  • Offers analysis, visualization, validation, and benchmarking functionalities for missense mutations.
  • Provides a catalog of all 71 million possible missense variants in the human genome.
  • Ensures data privacy by never training on user-submitted data.

use cases

Who Should Use AlphaMissense?

AlphaMissense is designed for professionals engaged in genetic research, clinical diagnostics, and therapeutic development, offering tools to enhance understanding and management of genetic variations.

  • Researchers: To prioritize resources, accelerate studies in molecular biology, clinical, and statistical genetics, and investigate missense mutations in human protein-coding genes.
  • Clinicians: For aiding in patient diagnosis, particularly for rare genetic disorders, and interpreting variants of unknown significance (VUS).
  • Scientists: Working to understand genetic variation and disease, to illuminate how specific amino acid changes impact protein function and to support therapeutic development.

how to use

How to Use AlphaMissense

AlphaMissense can be accessed via its web portal or integrated into research workflows through its R package, allowing users to query and analyze missense variant predictions.

  • 1Navigate to the AlphaMissense web portal (alphamissense.org).
  • 2Search for specific missense variants by gene name, protein identifier, or genomic coordinates.
  • 3Review the assigned pathogenicity score (0-1) and classification (likely benign/pathogenic).
  • 4Utilize the provided visualization tools to understand the structural context of variants.
  • 5Integrate AlphaMissense data into existing research pipelines using the 'AlphaMissenseR' R package for programmatic analysis and comparison with other datasets like ClinVar.

pricing

AlphaMissense Pricing & Plans

AlphaMissense operates on a freemium model, providing access to its core prediction capabilities without direct monetary cost for standard usage.

  • Freemium: Access to the AlphaMissense web portal and its comprehensive catalog of missense variant predictions.

Pros

  • +High accuracy in predicting pathogenicity, with 90% precision on a large subset of the ClinVar database.
  • +Comprehensive coverage, classifying 89% of all 71 million possible missense variants in the human genome.
  • +Integration into major biological databases (Ensembl, UniProt, DECIPHER, AlphaFold DB) enhances accessibility and utility.
  • +Leverages advanced deep learning and AlphaFold methodology for robust predictions based on structural context.
  • +Provides a valuable resource for prioritizing research and aiding in the diagnosis of genetic disorders.

Cons

  • −Clinical utility in decision-making still requires additional validation, as highlighted by several studies.
  • −Accuracy can be gene-dependent, meaning performance may vary across different genes.
  • −The tool does not offer a public API for direct programmatic integration, limiting automated workflows beyond the 'AlphaMissenseR' package.
  • −One study noted that it does not rely completely on AlphaFold2's structural contexts, which might impact certain predictions.

Similar Tools

AlphaMissense vs Competitors

AlphaMissense distinguishes itself in the landscape of genetic variant prediction tools through its deep learning architecture, foundation in AlphaFold, and comprehensive coverage.

1
REVEL↗

REVEL is an ensemble method that integrates scores from 13 individual prediction tools to provide a comprehensive pathogenicity score for rare missense variants.

Unlike AlphaMissense's deep learning model based on protein sequences and structural context, REVEL combines multiple existing predictors. Both aim to classify missense variants, but REVEL focuses on rare variants and provides a score from 0 to 1, with higher scores indicating greater likelihood of being disease-causing.

2
CADD↗

CADD provides a single, genome-wide deleteriousness score for all types of variants (SNVs and indels), integrating over 60 diverse genomic features.

While AlphaMissense specifically targets missense variants using deep learning, CADD offers broader applicability across all variant types, providing a PHRED-like score that ranks deleteriousness rather than a direct pathogenic/benign classification.

3
PathoPredictor↗

PathoPredictor is an interpretable machine-learning framework designed to distinguish pathogenic from benign missense variants using curated clinical variant data and functional annotations.

Similar to AlphaMissense, PathoPredictor uses machine learning for missense variant classification, but it emphasizes interpretability and is trained on curated clinical data, whereas AlphaMissense leverages protein sequences and structural context from AlphaFold methodology.

4
PrimateAI-3D↗

PrimateAI-3D quantifies missense variant pathogenicity using a deep-learning network trained on genetic variants from 233 primate species, leveraging evolutionary conservation across primates.

Both AlphaMissense and PrimateAI-3D utilize deep learning and evolutionary data for missense variant prediction. PrimateAI-3D specifically focuses on primate genetic variants for training, while AlphaMissense builds on the AlphaFold methodology and uses databases of related protein sequences and structural context.

Visit AlphaMissense↗

AI Reputation Report

Is AlphaMissense yours?

ChatGPT, Perplexity, Gemini, Claude & Grok answer buyer questions about AlphaMissense every day. See whether they name AlphaMissense — or send buyers to a rival.

See what AI saysfree preview

Featured in articles